New Delhi [India], November 10 (ANI/PNN): NDR Auto Component (NSE - NDRAUTO & BSE - 543214), engaged in the business of manufacturing seating solutions like frames and trims to four wheelers and two wheelers vehicles, has announced its unaudited Financial Results for the Q2 & H1 FY23
"We are also taking a number of additional steps to become a leaner and more efficient company by cutting discretionary spending and extending our hiring freeze through Q1," said Meta CEO Mark Zuckerberg in a statement on Wednesday.
Bajaj Electricals on Tuesday reported a marginal decline in its consolidated net profit to Rs 62 crore for the second quarter ended September 30 (Q2). It had Rs 62.55-crore net profit during the July-September quarter the previous fiscal, the company said in a regulatory filing. Net sales sl
Presently, anti-army sentiments are highly visible in Pakistan. People continue to voice their opinion against the military on social media despite accounts being suspended and arrests being made of people accused of planning anti-army campaigns on the internet.
Following recent tradition, all three of the new inductees will be honoured in a special presentation ceremony which will take place prior to the start of play at the first semi-final of the ICC Men's T20 World Cup 2022 at the Sydney Cricket Ground on Wednesday, November 9.
On a quarterly basis, Paytm's net losses have reduced by 11 per cent. The company said robust traction across all its businesses helped it achieve stronger revenue growth, with improvement in Ebitda before Esop cost (improvement of Rs201 crore in last two quarters).
The company said its performance was impacted due to spiralling increase in the price of input materials, resulting in higher cost which could not be compensated in the market due to huge supply overhang.
Bengaluru (Karnataka) [India], November 7 (ANI/BusinessWire India): Puravankara reports highest ever sales for Q2 and for H1 of any financial year since inception.
Hyderabad (Telangana) [India], November 7 (ANI/NewsVoir): Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the second quarter of FY23.